4
Changes in Ownership
Avalyn Pharma Inc. Filed Acc 0001193125-26-201856
Options or other derivatives
- Chief Executive Officer acquired 501,033 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Baranowski Lyn Chief Executive Officer | 2026-04-29 | Grant or award · Stock Option (Right to Buy) | +501,033 | 501,033 | D | ||
Loading xslF345X06/ownership.xml…